Alexander S. Dukhanin

Alexander S. Dukhanin

Auto-generated profile, based on publicly available information

Alexander S. Dukhanin

Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Cell Adhesion & Migration
Verified
Journal Article
Open access
EDElena A. Dukhanina
Elena A. Dukhanina
TPTatiana N. Portseva
Tatiana N. Portseva
ADAlexander S. Dukhanin
Alexander S. Dukhanin
SGSofia G. Georgieva
Sofia G. Georgieva
The study’s aim was to investigate the S100A4-mediated mechanisms of the regulation of tumor cell proliferation and migration in the human triple-positive breast carcinoma cell line MCF-7 (TPBC) and triple-negative breast carcinoma cell line MDA-MB-231 (TNBC). The proliferative activity of TNBC more than doubled during the incubation in the conditioned medium of TPBC. Extracellular S100A4 dose-dependently decreased the proliferative response of TPBC. TPBC negatively impacted the growth of TNBCs during their co-culturing. TPBC significantly decreased the migration activity of the TNBC cells while the S100A4 intracellular level in the TNBC was also decreasing. The decrease in the S100A4 intracellular level occurred due to the protein’s monomeric form while the contribution of the dimeric form into the overall S100A4 concentration in TNBC cells increased 1.5-2-fold. The S100A4 pathway in the intercellular communication between TNBC and TPBCs also included the dexamethasone-sensitive mechanisms of S100A4 intra- and extracellular pools regulation.

26 September 2022 in Лечащий врач
Verified
Journal Article
Closed access
ADA.S. Dukhanin
A.S. Dukhanin
The literature review presents current data on the origin and sources of industrial production of vitamin D, and describes the features of metabolism, biological and pharmacological properties of various vitamin D vitamers. Vitamin D vitamers are groups of structurally similar molecules that differ in the presence of certain functional groups and biological activity. The role of micellization in the mechanisms of absorption and assimilation of cholecalciferol is considered in detail; justified pharmaceutical technologies that improve its bioavailability. Depending on the dosage form and time of appearance in the Russian Federation, it is proposed to classify vitamin D drugs in the Russian Federation into three generations. First generation – fish oil preparations; second-generation drugs – vitamin D in an oil solution; the third generation – vitamin D as part of an aqueous solution of micelles. Preparations of the 3rd last generation, at the moment, are the most modern, as they level out the shortcomings of the previous two generations (fish oil and oil solution), and have the main advantage – high bioavailability, regardless of the patient's gastrointestinal diseases and the composition of the accompanying food (due to the content of finished micelles). The indications for the use of vitamin D preparations for the treatment, prevention and maintenance of the target level of vitamin D in children and adults are summarized, depending on the active substance (cholecalciferol, ergocalciferol) and its dosage form (drops, tablets, capsules).

18 November 2018 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
EDE. A. Dukhanina
E. A. Dukhanina
TPT. N. Portseva
T. N. Portseva
ADA. S. Dukhanin
A. S. Dukhanin
SGS. G. Georgieva
S. G. Georgieva

14 May 2024 in Russian Journal of Skin and Venereal Diseases
Verified
Journal Article
Open access
PDF file
OOOlga Yu. Olisova
Olga Yu. Olisova
ALAnfisa Lepekhova
Anfisa Lepekhova
ADAlexander S. Dukhanin
Alexander S. Dukhanin
NTNatalia P. Teplyuk
Natalia P. Teplyuk
NSNikolai lvovich Shimanovskii
Nikolai lvovich Shimanovskii
ТПТеплюк Наталия Павловна
Теплюк Наталия Павловна
BACKGROUND: Autoimmune bullous dermatoses are known to be the most severe blistering conditions of skin. HLA-DRB1 and DQB1 alleles might play a crucial role in their onset. In pemphigus HLA class II molecules stimulate the division of T helper cells, which in turn stimulate B cells to produce antibodies to epidermal keratinocytes causing acantholysis. The HLA-DRB1 and DQB1 alleles’ frequencies studied in pemphigus in a vast variety of populations worldwide. However, as of yet, this mechanism was not investigated in Russian population. AIM: To estimate the prevalence of the HLA-DRB1 and DQB1 alleles at a low- and high-resolution levels in patients with various forms of pemphigus. We observed 86 patients with pemphigus vulgaris, 13 ― with pemphigus foliaceus, 6 patients with paraneoplastic pemphigus and 92 healthy volunteers. MATERIALS AND METHODS: HLA typing for DRB1 and DQB1 was performed with 50 nanogram DNA extraction and polymerase chain reaction. RESULTS: At a low-resolution level HLA-DRB1*4 and DRB1*14 alleles were statistically significant more frequent in pemphigus vulgaris and pemphigus foliaceus patients compared to those in control subjects, whereas HLA-DRB1*11, DRB*16, and DRB1*3 alleles were more frequent in healthy volunteers. At a high-resolution level, DRB1*04:02 allele was observed to show its statistically significant higher frequency in all variants of pemphigus, including paraneoplastic pemphigus. However, DRB1*14:05 HLA allele was more frequent in pemphigus vulgaris and pemphigus foliaceus patients, whereas DRB1*11:04 one was found to be 3.7 times more frequent in healthy controls. Additionally, at a low-resolution level for HLA-DQB1 alleles no statistically significant results were observed. However, at a high-resolution level the chances for more frequent indication of DQB1*03:02 allele were 7.09 times higher in pemphigus foliaceus group and 2.49 higher in pemphigus vulgaris patients compared to healthy volunteers. Moreover, DQB1*05:03 was identified more frequently in pemphigus vulgaris and paraneoplastic pemphigus groups of patients, whereas DQB1*03:01 allele was shown to be increased in the group of healthy donors. CONCLUSION: HLA-DRB1*4, DRB1*14, DRB1*04:02, DRB1*14:05, DQB1*03:02 and DQB1*05:03 alleles might be considered as the genetic markers for pemphigus vulgaris susceptibility, while HLA-DRB1*11, DRB*16, DRB1*3, DRB1*11:04 and DQB1*03:01 allelic groups appear to be protective for Russian population.

1 January 2024 in Dermatologic Therapy
Verified
Journal Article
Open access
PDF file
ALAnfisa Lepekhova
Anfisa Lepekhova
OOOlga Olisova
Olga Olisova
NSNikolai lvovich Shimanovskii
Nikolai lvovich Shimanovskii
NTNatalia Teplyuk
Natalia Teplyuk
EZElizaveta Zhgelskaya
Elizaveta Zhgelskaya
ADAlexander Dukhanin
Alexander Dukhanin
There are two main isoforms of glucocorticoid receptor (GR) α‐ and β‐isoforms. GRβ isoform is the dominant inhibitor of the GRα receptor and plays a significant role in a poor response to systemic glucocorticoids (GCs) under numerous conditions. The A3669G (rs6198) polymorphism (SNP) in the untranslated region of human GR stabilizes the mRNA of the dominant‐negative GRβ isoform. However, the mechanisms which generate mRNA encoding the GRβ isoform have been poorly defined, especially in pemphigus patients who do not respond to GCs. The main aim was to study gene SNP of GR in patients with pemphigus vulgaris (PV) and healthy controls. We investigated whether the A3669G SNP of the human GRβ gene is a susceptibility allele for PV and contributes to GC resistance development. The presence of the A3669G SNP was determined by high‐resolution melting analysis and then confirmed by direct sequencing. GR A3669G SNP (AG genotype) occurred more frequently in PV patients (n = 72; 25%) compared with healthy controls (n = 92; 3.2%; p < 0.001). Allele G was significantly more presented in PV patients (p < 0.001). Out of 48 patients with AA genotype of A3669G SNP, only 6 had GC resistance, whereas 11 out of 18 with AG genotype developed GC resistance (p < 0.0001). The frequency of a poor response to GC in the group of patients with AG genotype was 4.89 times higher compared to AG negative one (p < 0.0001).Our study showed that the A3669G SNP was more present in PV patients. Moreover, GC resistance appeared more frequently in patients with the AG genotype (p < 0.0001). Since those patients predominantly with severe pemphigus had GC resistance (p = 0.001), we feel that A3669G SNP (AG genotype) contributes to its development. However, more studies are needed to determine whether A3669G SNP of the human GR gene associated with the disease severity and poor response to GCs in these patients.

29 December 2020 in Russian Journal of Allergy
Verified
Journal Article
Open access
PDF file
ADAlexander S. Dukhanin
Alexander S. Dukhanin
ДСДуханин Александр Сергеевич
Духанин Александр Сергеевич
Differences between individual antihistamines are determined by such pharmacokinetic properties as the rate and completeness of absorption, half-life, the participation of hepatic and renal mechanisms of elimination from the body. Pharmacodynamic features of the antihistamine include selectivity and affinity for histamine H1-receptors and the presence of central effects. The mechanisms of the development of unwanted drug interactions with second-generation antihistamines are analyzed in detail. Three levels of interaction have been identified: 1) hepatic enzymes of the P450 system; 2) membrane carriers of organic anions (OATP) transport proteins on the sinusoidal membrane of hepatocytes and the luminal membrane of the epithelium of the proximal nephron tubule; 3) P-glycoprotein (Pgp, ABCB1-protein) of epithelial cells of the small intestine the area of absorption of oral forms of antihistamines, the epithelium of the proximal tubule and the BBB (blood-brain barrier). The emphasis is made on the description of the dependence of the pharmacological profile of antihistamines on its chemical structure. The elasticity of the bilastine molecule, the ability to induce a change in conformation underlies the high complementarity of bilastine to the recognition site of the H1-receptor which is a high affinity. Experimental evaluation confirms this conclusion: the dissociation constant (Dс) of the bilastin-receptor complex is in the nM concentration range. The bilastine molecule, as a representative of antihistamines with zwitterionic properties, carries both a positive and a negative charge at a physiological pH, making it difficult for its penetration into the brain. The peculiarities of the chemical nature of the bilastine molecule are reflected in the specific pharmacological profile of AGP. In vitro studies have shown a high specific affinity of bilastine for H1-receptors with a very low affinity for other histamine receptors (H2, H3, H4), serotonin, bradykinin, muscarinic and adrenergic receptors). According to this indicator, bilastine is 3 times higher than cetirizine and 5 times higher than fexofenadine. Bilastine is practically not metabolized in the body and is excreted mainly unchanged, and also does not have a cardiotoxic effect. Bilastine is well tolerated; as a therapeutic dose it has a less pronounced sedative potential compared to other second-generation antihistamines.